2012
DOI: 10.1016/j.ejmech.2012.02.028
|View full text |Cite
|
Sign up to set email alerts
|

Metal–ligand interactions: An analysis of zinc binding groups using the Protein Data Bank

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
38
0

Year Published

2014
2014
2019
2019

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 41 publications
(41 citation statements)
references
References 15 publications
3
38
0
Order By: Relevance
“…2,3 In the majority of these examples, the small molecule inhibitors possess functional groups that bind to the active site metal ion of the enzyme; 4 a relatively small selection of such groups, including carboxylates, phosphates, and hydroxamic acids, are commonly employed as the metal-binding groups (MBGs) of choice. 5 Recently, a number of efforts have focused on the development of alternative MBGs to these commonly employed groups, 6 and indeed some newer metalloprotein inhibitors, such as raltegravir and dolutegravir against HIV integrase (HIV1 IN, Mg 2+ -dependent), employ more sophisticated heterocyclic MBGs. 79 These next-generation MBGs have the potential to improve the potency, selectivity, and pharmacokinetics of metalloprotein-targeted therapeutics.…”
Section: Introductionmentioning
confidence: 99%
“…2,3 In the majority of these examples, the small molecule inhibitors possess functional groups that bind to the active site metal ion of the enzyme; 4 a relatively small selection of such groups, including carboxylates, phosphates, and hydroxamic acids, are commonly employed as the metal-binding groups (MBGs) of choice. 5 Recently, a number of efforts have focused on the development of alternative MBGs to these commonly employed groups, 6 and indeed some newer metalloprotein inhibitors, such as raltegravir and dolutegravir against HIV integrase (HIV1 IN, Mg 2+ -dependent), employ more sophisticated heterocyclic MBGs. 79 These next-generation MBGs have the potential to improve the potency, selectivity, and pharmacokinetics of metalloprotein-targeted therapeutics.…”
Section: Introductionmentioning
confidence: 99%
“…According to ZBG studies, using the coordinates of protein-ligand complex structures obtained from the PDB, the most frequently found ZBG is carboxylate, followed by sulfonamide, hydroxamate, and phosphonate/phosphate. Whereas carboxylates bound to the zinc via both monodentate and bidentate interactions, the hydroxamates bound dominantly in a bidentate manner [19]. The median distances from the nitrogen, oxygen, and sulfur atoms were 1.99, 2.05, and 2.28 Å respectively.…”
Section: Docking Studies On Mmp-9mentioning
confidence: 93%
“…The reaction mixture was then cooled to room temperature and the solid precipitated was filtered off and washed with toluene (or filtered, after the mixture was concentrated in vacuo (19), and then taken up with an aqueous solution of 10 % Na 2 CO 3 and washed with water, as for 18). The crude product was then purified by flash chromatography and recrystallized or directly recrystallized.…”
Section: 3-thiazolidin-3-yl)propanamides 13-19mentioning
confidence: 99%
“…Zn 2+ is believed to be one of the most potent inhibitor of proton channels. The inhibitory action of Zn 2+ is derived from the metal ion binding to histidine residues, and also to the thiol group of the cysteine residues (43). In fact, it has been reported that Zn 2+ does not inhibit NADH oxidation at the flavin site or intramolecular electron transfer in complex I, but it does inhibit proton transfer to bound quinone or proton translocation (25).…”
Section: +mentioning
confidence: 99%